Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome
- PMID: 1303261
- DOI: 10.1038/ng1092-128
Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome
Abstract
A predisposing gene for breast and ovarian cancer has recently been mapped to chromosome 17q12-21. If this gene is a tumour suppressor gene, allele losses would be expected in the tumours of affected family members and the losses should affect the wild-type chromosome, reflecting the need for inactivation of the wild-type allele at the predisposing locus. In four multiple case breast-ovarian cancer families, we have found that in each of nine tumours which showed allele losses, the losses were from the wild-type chromosome. This suggests that the putative 'breast-ovarian' cancer gene is indeed a tumour suppressor gene.
Similar articles
-
Detection of allelic losses on 17q12-q21 chromosomal region in benign lesions and malignant tumors occurring in a familial context.Oncogene. 1994 Feb;9(2):437-42. Oncogene. 1994. PMID: 8290255
-
A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus.Cancer Res. 1993 Mar 15;53(6):1218-21. Cancer Res. 1993. PMID: 8095178
-
Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.Clin Cancer Res. 1995 May;1(5):539-44. Clin Cancer Res. 1995. PMID: 9816013
-
The search for the familial breast/ovarian cancer gene.Trends Genet. 1993 Jan;9(1):22-6. doi: 10.1016/0168-9525(93)90068-S. Trends Genet. 1993. PMID: 8434413 Review.
-
[The importance of genetic factors for development of breast cancer].Zentralbl Gynakol. 1994;116(12):660-9. Zentralbl Gynakol. 1994. PMID: 7846977 Review. German.
Cited by
-
A continuum model for tumour suppression.Nature. 2011 Aug 10;476(7359):163-9. doi: 10.1038/nature10275. Nature. 2011. PMID: 21833082 Free PMC article. Review.
-
Loss of heterozygosity studies in tumors from families with breast-ovarian cancer syndrome.Hum Genet. 1994 Sep;94(3):231-4. doi: 10.1007/BF00208275. Hum Genet. 1994. PMID: 8076936
-
Molecular cloning of BRCA1: a gene for early onset familial breast and ovarian cancer.Breast Cancer Res Treat. 1993 Nov;28(2):121-35. doi: 10.1007/BF00666425. Breast Cancer Res Treat. 1993. PMID: 8173065 Review.
-
The biological effects and clinical implications of BRCA mutations: where do we go from here?Eur J Hum Genet. 2016 Sep;24 Suppl 1(Suppl 1):S3-9. doi: 10.1038/ejhg.2016.93. Eur J Hum Genet. 2016. PMID: 27514841 Free PMC article. Review.
-
Functional annotation of variants of the BRCA2 gene via locally haploid human pluripotent stem cells.Nat Biomed Eng. 2024 Feb;8(2):165-176. doi: 10.1038/s41551-023-01065-7. Epub 2023 Jul 24. Nat Biomed Eng. 2024. PMID: 37488236 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical